Improvements in treatment technologies consistently push the medical community to assess the potential benefits, risks, and costs. As proton therapy becomes more accessible, studies will be used to evaluate the most broadly beneficial ways to use the limited resource.
Clinical trials have a vital role in the advancement of medicine. Physicians rely on sound clinical evidence which meets strict scientific standards, along with their personal experience and knowledge of the patient, to guide treatment decisions. Medical societies and insurance companies also use the results of studies to create treatment and coverage guidelines.
Proton therapy got positive billing at the recent Particle Therapy Cooperative Group, as researchers from across the country presented findings that showed proton therapy reduced potentially life-altering side effects and improved survival rates for cancer patients.
“You might live three to five years.”
Those were the words that greeted Stephanie Story when she met with the specialist she’d been referred to after her second diagnosis of breast cancer. (more…)
Diagnosing Alzheimer’s disease early is key to helping delay onset and manage the disease.
The Center for Biomedical Research is the first in the state of Tennessee to be approved for participation in a clinical trial known as the Imaging Dementia—Evidence for Amyloid Scanning, or IDEAS—study. (more…)
Three years after Provision opened the doors of its proton therapy center, awareness and demand for the treatment are growing—as is evidence of its effectiveness in treating various cancers, including prostate cancer and breast cancer.
At the National Association for Proton Therapy conference last week, Provision was well represented as employees spoke about ways technology, marketing and research are continuing to help boost proton therapy’s presence and use in providing quality care. (more…)
If you ‘heart’ your ‘heart,’ a growing number of studies demonstrate that treating cancer with protons helps reduce the risk of heart disease due to radiation exposure. This is especially important for breast cancer patients, whose cardiovascular systems can suffer from conventional radiation spilling over into the heart and lungs.
With breast cancer getting lots of attention this time of year, women should know that research has shown patients experience excellent survival rates and cosmetic results with proton therapy.
Loma Linda University’s Proton Treatment and Research Center conducted the clinical trial on patients with early stage invasive (non lobular) breast cancer. The 2014 study, “Partial Breast Radiation Therapy With Proton Beam: 5-Year Results With Cosmetic Outcomes,” represents the most solid data set to date on proton therapy and breast cancer outcomes. (more…)
The spotlight recently shone on proton therapy by the International Journal of Radiation Oncology-Biology-Physics, known as the Red Journal, marks a milestone in its recognition as an established treatment for cancer.
It also holds good news for patients considering their treatment options. (more…)
The prestigious International Journal of Radiation Oncology-Biology-Physics, or Red Journal, has devoted an entire issue to the subject of particle therapy—bringing protons into the limelight of medical practice. It is the official journal of the American Society for Radiation Oncology.
Much of the nearly 600-page issue, nearly double the normal size, includes 75 articles ranging from clinical outcomes to commentary on a modality increasingly gaining recognition as a preferred option for treatment of tumors. (more…)